Category: Finance | Title: Zenzedi Pill: Generic Amphetamine Salt Combo for ADHD Treatment | Tag: ADHD medication | Meta Description: Zenzedi pill is a generic amphetamine salt combo for ADHD, with FDA approval, active ingredients, dosage, and side effects explained...
What Is Zenzedi Pill
Zenzedi pill is a brand name for a generic immediate-release amphetamine salt combo tablet used to treat attention deficit hyperactivity disorder. It contains a mixture of amphetamine aspartate monohydrate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate, the same active ingredients found in branded ADHD stimulants. Zenzedi is manufactured by Barr Laboratories, a subsidiary of Teva Pharmaceutical Industries, and is available in multiple dosage strengths approved by the U.S. Food and Drug Administration. The formulation is classified as a Schedule II controlled substance due to its high potential for abuse and dependence. Patients use Zenzedi pill as part of a total treatment program that includes psychological, educational, and social measures. For background on amphetamine-based ADHD therapies, see the overview at FDA Psychopharmacologic Drugs.
The Zenzedi pill works by increasing the levels of certain neurotransmitters in the brain, primarily dopamine and norepinephrine, which help improve focus, attention, and impulse control. It is indicated for the treatment of ADHD in children aged six years and older and in adults. The tablets are immediate-release, meaning they begin to take effect within 30 to 60 minutes after ingestion. The duration of clinical effect typically lasts four to six hours, requiring multiple daily doses for symptom management. Zenzedi is bioequivalent to its reference listed drug, meaning it must meet the same strict standards for identity, strength, quality, and purity. The FDA's Orange Book lists Zenzedi as an approved therapeutic equivalent to brand-name ADHD stimulants.
Zenzedi Pill Dosage and Forms
Zenzedi pill is available as immediate-release tablets in strengths of 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. The tablets are round, scored, and imprinted with the Zenzedi name and dosage strength for easy identification. The usual starting dose for children is 5 mg once or twice daily, while adults may start at 10 mg or 20 mg once or twice daily. Dosage is titrated in small increments at weekly intervals based on therapeutic response and tolerability. Maximum daily dosage for adults is typically 40 mg, and for children it is 30 mg. The tablets can be swallowed whole or crushed and mixed with water if needed. Detailed prescribing information is available in the FDA-approved labeling at Drugs@FDA.
Common side effects of Zenzedi pill include decreased appetite, dry mouth, insomnia, headache, dizziness, and weight loss. Serious adverse events may include cardiovascular events, psychiatric symptoms such as hallucinations or mania, and circulation problems like Raynaud's phenomenon. The drug carries a boxed warning for the potential for abuse and dependence, and it should be used only under careful medical supervision. Patients with a history of heart disease, hypertension, or psychiatric disorders should discuss risks with their healthcare provider before starting treatment. The manufacturer provides a Medication Guide with each prescription to inform patients about these risks. The Centers for Disease Control and Prevention offers additional data on ADHD medication use at CDC ADHD Treatment.
Zenzedi Pill Market and Availability
Zenzedi pill entered the U.S. market as a generic alternative to branded amphetamine salt combo products following patent expiration. Teva Pharmaceutical Industries, through its subsidiary Barr Laboratories, secured FDA approval for the generic formulation, allowing it to compete in the ADHD stimulant market. The generic version is typically priced lower than the brand-name counterpart, making it a cost-effective option for patients and healthcare systems. Zenzedi is dispensed by retail pharmacies such as CVS